maternal depression

New Study Estimates the Astonishing Cost of Neglected Perinatal Mood and Anxiety Disorders in US Mothers

A recently published article in the American Journal of Public Health has attributed a substantial financial cost to untreated perinatal mood and anxiety disorders among mothers. The study, conducted by researchers with the think [...]

By |2025-12-11T09:48:31-04:00May 13th, 2020|Psychiatric Disorders During Pregnancy|Comments Off on New Study Estimates the Astonishing Cost of Neglected Perinatal Mood and Anxiety Disorders in US Mothers

If We Are So Concerned About Maternal Mental Health, Why Don’t We Have More Mother-Baby Mental Health Programs? 

The American College of Obstetricians and Gynecologists (ACOG) now recommends screening for perinatal depression, stating that “clinicians screen patients at least once during the perinatal period for depression and anxiety symptoms using a standard, [...]

By |2020-07-24T11:10:33-04:00January 15th, 2020|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on If We Are So Concerned About Maternal Mental Health, Why Don’t We Have More Mother-Baby Mental Health Programs? 

Prenatal Exposure to Maternal Depression and SSRIs Affect Network Connectivity, But in Different Ways

While we have considerable data regarding the reproductive safety of antidepressants, including the selective serotonin reuptake inhibitors (SSRIs), most studies have focused on the prevalence of major malformations in children with prenatal exposure to [...]

By |2020-07-24T10:51:35-04:00January 14th, 2020|Depressive Disorders, Mood Stabilizers, Pregnancy & Medications, Psychiatric Disorders During Pregnancy|Comments Off on Prenatal Exposure to Maternal Depression and SSRIs Affect Network Connectivity, But in Different Ways

Bonding Problems Emerge Early and Persist Across the First Year of Life

A mother’s emotional relationship with her baby begins during her pregnancy.  After her baby is born, the mother’s feelings about her baby, described as bonding, typically grow and intensify and become the foundation of the [...]

By |2019-12-10T16:31:14-04:00December 11th, 2019|Postpartum Psychiatric Disorders|Comments Off on Bonding Problems Emerge Early and Persist Across the First Year of Life

Maternal Depression, But Not Exposure to SSRIs, Associated with Worse Executive Functioning in Children  

While we have considerable data on the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy, most of this research focuses on the risk of congenital malformations in exposed children.  We have far less [...]

By |2020-08-03T12:26:08-04:00January 16th, 2019|Perinatal Substance Use, Psychiatric Disorders During Pregnancy|Comments Off on Maternal Depression, But Not Exposure to SSRIs, Associated with Worse Executive Functioning in Children  

Fetal exposure to depression: How does ‘dose’ figure in?

The following post was first published in OB/GYN News. Please see our OB/GYN News archives here. Publish date: April 23, 2018 The last two decades have seen an ever-growing number of reports on risks of fetal exposure to [...]

By |2018-09-10T12:34:18-04:00May 7th, 2018|Depressive Disorders, ObGyn News, Pregnancy & Medications, Psychiatric Disorders During Pregnancy|Comments Off on Fetal exposure to depression: How does ‘dose’ figure in?

Worse Pregnancy Outcomes in Women with More Chronic Depressive Symptoms

Over the last decade we have seen multiple studies which have demonstrated an association between the use of antidepressants during pregnancy and increased risk of certain adverse outcomes, including preterm birth and low birth weight. [...]

By |2018-09-10T12:34:30-04:00February 28th, 2018|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on Worse Pregnancy Outcomes in Women with More Chronic Depressive Symptoms

Brexanolone: Related to Allopregnanolone, Effective for the Treatment of Postpartum Depression

In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of severe postpartum depression.  SAGE-547, now called brexanolone, is an allosteric modulator of GABAA receptors.  This drug was initially under [...]

By |2017-05-10T09:40:41-04:00May 10th, 2017|Medication, Postpartum Depression, Postpartum Psychiatric Disorders, Treatment|Comments Off on Brexanolone: Related to Allopregnanolone, Effective for the Treatment of Postpartum Depression

How Does Postpartum Anxiety Affect Infants and Young Children?

Many studies have documented the finding that exposure to maternal psychiatric illness early on in the child’s life may adversely affect the child’s cognitive, emotional and behavioral development. These early studies focused on the impact [...]

By |2017-01-30T10:36:21-04:00January 30th, 2017|Anxiety Disorders, Postpartum Psychiatric Disorders|Comments Off on How Does Postpartum Anxiety Affect Infants and Young Children?
Go to Top